-
South Korea baseball league cancels two games over heatwave
-
Search resumes for missing climbers from Pakistan avalanche
-
US drops Reflecting Pool case, admits damage due to botched renovation
-
Warsaw and Kyiv exhume Volyn victims at centre of diplomatic quarrel
-
Russian attacks on Kyiv kill 9, wound more than two dozen
-
India PM Modi says he forgives protesters who abused him
-
Injured Australian swim star O'Callaghan pulls out of PanPacs
-
Veteran Wallabies playmaker Quade Cooper eyes World Cup comeback
-
California lifeguards wiped out from extreme weather
-
FIFA scraps private investment plan after backlash
-
FIFA scraps private investment plan after backlash: Infantino
-
US plans steep water cuts for southwest amid Colorado River crisis
-
South Africa's WAFCON hopes hang in the balance after dramatic draw
-
Nakashima ousts top seed de Minaur, Osaka advances at Washington
-
Hunter Bell cruises to Commonwealth gold, Pathirage stuns javelin stars
-
Nakashima ousts top seed de Minaur and Osaka advances at Washington
-
Amazon surges as US stocks shrug off bond yield worries
-
Nakashima ousts defending champion de Minaur to reach Washington semis
-
Google rolls back new satellite image AI tool after backlash
-
Magaia salvages last-gasp WAFCON draw for South Africa
-
Ryu leads in bid for third straight major at women's British Open
-
Forever chemicals and pesticides under Trump: what to know
-
Fire-hit France region 'coming up for air' as main blaze calms
-
US announces steep water cuts for three states amid Colorado River crisis
-
Wembanyama to get signature shoe in Nike contract extension: reports
-
EU grapples with migrant crisis in Spain's N. Africa enclave
-
Oil giants report blowout profits on war, warn high gas prices could persist
-
Hungary to shut nuclear plant as heatwave hits central Europe
-
Google launches new satellite image AI tool, alarming researchers
-
Strengthening El Nino 'adding fuel to a planet already on fire': UN chief
-
Eddie Howe resigns as Newcastle boss to 'recharge'
-
Tech-fuelled rally fizzles as oil prices rise
-
High winds hamper firefighting efforts in western Turkey
-
Chelsea's Mudryk cleared to play after doping ban appeal
-
Howe resigns as Newcastle boss
-
A side of oysters for France's flat-out firefighters
-
Full-scale tour will benefit All Blacks, says coach Rennie
-
England cricket chief Key refuses to rule out Stokes return
-
US Fed dissenters call for rate hikes over sustained inflation
-
New blazes in Greece as strong winds hamper firefighting
-
Trump and far-right seize on Spanish migration crisis
-
Springboks star Feinberg-Mngomezulu back for Argentina Test
-
Hamas agrees to disarm under Trump plan
-
Shops closed, businesses quiet as Spain's Ceuta faces migrant surge
-
French, Italian winegrowers face earliest ever harvest
-
Chelsea fined £10mn, handed suspended transfer ban for breaching agent rules
-
Alarm over climate-linked low level of German waterways
-
Residents defend Spain’s ancient 'El Abuelo' tree from flames
-
UK court rejects challenge against new Chinese embassy in London
-
Forever chemicals and pesticides: what to know
Coalition of states vows to protect access to abortion pill under Trump review
A coalition of attorneys general across states including New York, Minnesota and Arizona vowed Monday to protect access to mifepristone, the medication used in the majority of abortions in the United States.
The move comes as the Trump administration has reportedly launched a review into the medication's safety, in what many abortion rights' organizations have dubbed a blatant attempt to undermine health care access.
"The decision to reexamine access to this medication was made in response to a scientifically baseless letter and ignores decades of research that prove mifepristone is safe and effective," read the joint statement that included New York's Attorney General Letitia James, who co-led the coalition of 20 officials in the effort.
"Medical decisions should be left between patients, their families, and their providers – and they should be guided by science, not political agendas," the statement continued.
"If access to mifepristone is challenged, we will take action to protect it," it added.
Officials who co-signed the initiative represented Arizona, California, Colorado, Connecticut, Delaware, Hawaii, Illinois, Maine, Maryland, Massachusetts, Michigan, Minnesota, New Jersey, New Mexico, Oregon, Rhode Island, Vermont, Washington state, and the District of Columbia.
Trump's health chief Robert F. Kennedy Jr and FDA Commissioner Marty Makary reportedly delivered a letter to 22 Republican attorneys general saying that the FDA was conducting its own review of the pill.
Proponents of reviewing mifepristone's safety have cited a study -- which was not peer-reviewed and published on a website, not in a scientific journal -- conducted by a conservative think-tank.
The Ethics & Public Policy Center (EPPC) says its priorities include "pushing back against the extreme progressive agenda while building a consensus for conservatives."
The medication has been used for 25 years in the United States. It is the most common method for abortion care and also routinely used for managing early miscarriage.
Mifepristone, which prevents pregnancy progression, and misoprostol, which empties the uterus, are approved to terminate a pregnancy up to 70 days of gestation in the United States.
N.Schaad--VB